AHIMA Reacts in Support of NAHIT's New Strategic and Operating...( An Official Sta...)
Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
AHIMA Reacts in Support of NAHIT's New Strategic and Operating Framework
Date:6/5/2008
An Official Statement from AHIMA
CHICAGO, June 5 /PRNewswire/ -- "AHIMA's Board of Directors applauds this very clear and urgent direction that promises to strengthen the effort to address health IT from a strategic perspective that still embraces the pure technological issues for senior executives. In addressing the need to realize real benefits from health IT, NAHIT is focusing on a critical leadership challenge. AHIMA will continue working to support the NAHIT mission and strategic goals.
"As a founding NAHIT member, we are proud of the strides made by this coalition of healthcare entities to supply and implement standards that provide administrative simplification and uniformity in the delivery of healthcare services."
Statement Attributable to: Linda L. Kloss, MA, RHIA
Chief Executive Officer
American Health Information Management Association
For more information contact: Craig May
AHIMA Public Relations Director
312-233-1544
773-716-8622 (cell)
'/>"/>
| SOURCE Linda L. Kloss, MA, RHIA Copyright©2008 PR Newswire. All rights reserved |
Related biology technology :
1. GeneNews announces management changes to support commercialization of ColonSentry(TM)
2. InterCure Supports AHA Endorsement of Home Blood Pressure Monitoring
3. AstraZeneca Supports Transparency Legislation on Payments to Health Care Providers
4. Albert Einstein College of Medicine Receives $25-Million Gift to Support Stem Cell and Epigenomic Research and Clinical Skills Training
5. Nikon Instruments Begins Direct Sales and Technical Support in Southern California and Rocky Mountain Territories
6. Hershey Center for Applied Research Supports Acceleration of Scientific Research and Development
7. European Regulatory Agency Supports OPAXIO(TM) Brand Name for Cell Therapeutics Lung Cancer Drug
8. Quest PharmaTech Receives Support from National Research Councils Industrial Research Assistance Program (NRC-IRAP) to develop Ultrasound Technology for the Treatment of Cancer
9. Alta Bates Summit Medical Center Opens Two Warm, Supportive Patient Centers: Carol Ann Read Breast Health Center and Family Resource Center
10. U.S. Army Awards General Dynamics Contract for Biological Detection System Production and Support
11. Consumer Advocate Testifies in Support of Stem Cell Oversight Legislation
Post Your Comments:
Breaking Biology Technology:Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 2Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 3Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 4Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 5Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 6Sirius Genomics Announces Change in Leadership 2Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 2Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 3Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 4
[0] Quest Diagnostics Declares Quarterly Cash Dividend[0] Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain[0] Sirius Genomics Announces Change in Leadership[0] Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea
Other Biology Technology:Mercury Therapeutics Patents Filed 2Mercury Therapeutics Patents Filed 3febit Forms Scientific Advisory Board 2febit Forms Scientific Advisory Board 3Boston Scientific Announces Sale of TriVascular Endovascular Aortic Repair Program 2Boston Scientific Announces Sale of TriVascular Endovascular Aortic Repair Program 3
Breaking Biology News(10 mins):New biological route for swine flu to human infections 2New biological route for swine flu to human infections 3First phase of pan-tropical forest mapping debuting at COP15 2First phase of pan-tropical forest mapping debuting at COP15 3Nanomedicine: Ending 'hit and miss' design 2Nanomedicine: Ending 'hit and miss' design 3Anthem Life 26 Disability Insurance Company offers The Healing Book to Help Young Life Insurance Beneficiaries Cope with the Loss of a Loved One 56226 1Anthem Life 26 Disability Insurance Company offers The Healing Book to Help Young Life Insurance Beneficiaries Cope with the Loss of a Loved One 56226 2Catholics for Choice Believes in Healthcare Reform Supports Federal Funding for Abortion 56222 1Catholics for Choice Believes in Healthcare Reform Supports Federal Funding for Abortion 56222 2BioSpecifics Technologies Corp to Present at Rodman 26 Renshaw 11th Annual Healthcare Conference 13853 1
Other Biology News:Bioinformatics reveals new gene regulation system 2Bioinformatics reveals new gene regulation system 3Study Finds Moderate Hypothermia A Safe Treatment For Traumatic Brain Injury In Kids 2
Biology Products:
Rabbit Anti-Fas-ligand Polyclonal Antibody, Unconjugated from Assay Designs/Stressgen BioreagentsAnti-Laminin alpha 2 (Merosin M chain) Monoclonal Antibody, Unconjugated, Clone 5H2 from CHEMICONGoat Anti-Human Rabenosyn 5 Polyclonal Antibody, Unconjugated from AbcamAnti-Acetyl CoA Carboxylase Antibody, Unconjugated from Cell Signaling Technology
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |